SHILPA MEDICARE LTD (India) holds 1 active US FDA Type II Drug Master File and 1 inactive, has DMF or CEP filings on record for 2 active ingredients and is linked to 3 FDA-registered manufacturing sites. 18 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “SHILPA MEDICARE LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/shilpa-medicare-ltd

Overview

SHILPA MEDICARE LTD is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering SUNITINIB.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which SHILPA MEDICARE LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

SHILPA MEDICARE LTD holds 1 active (2 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • SUNITINIBActive2021-04-21
  • ANASTROZOLEInactive2009-09-23

Registered manufacturing sites (3)

Physical sites registered with the US FDA and resolved to SHILPA MEDICARE LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

18 FDA enforcement records linked to this company.

  • recall — Class II2026-08-26

    Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials

  • recall — Class II2026-08-26

    Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials

  • 4832024-10-30

    Complete instructions, procedures, specifications et. al.

  • 4832024-10-30

    Calibration/Inspection/Checking not done

  • 4832024-10-30

    Signature and checking of records -- 2 persons

  • 4832024-10-30

    Written record of investigation incomplete

  • 4832023-03-10

    Following/documenting laboratory controls

  • 4832023-03-10

    Lab controls established, including changes

  • recall — Class II2020-12-16

    CGMP Deviations

  • recall — Class II2020-12-16

    CGMP Deviations

  • recall — Class II2020-12-16

    CGMP Deviations

  • recall — Class II2020-12-16

    CGMP Deviations

  • recall — Class II2020-12-16

    CGMP Deviations

  • recall — Class II2020-12-16

    CGMP Deviations

  • warning_letter2020-10-09

    FDA Warning Letter (drug product)

  • 4832019-09-06

    Written program not followed

  • 4832019-09-06

    Instruments, apparatus, et. al. not meeting specs

  • 4832019-02-13

    Lab controls established, including changes

For suppliers

Is this SHILPA MEDICARE LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.